Abstract：Objective: To summarize the pharmaceutical care experience from a patient with advanced renal cell carcinoma complicated with postoperative infection. Methods: The whole process of pharmaceutical care on the renal cell carcinoma patient with postoperative infection was expounded. Based on the patient’s individual condition, the clinical pharmacist discussed the anti-infection therapy regimen with clinicians and an appropriate medication was developed. Moreover, the adjuvant medication was applyed to alleviate the adverse reactions, such as bone marrow suppression and renal toxicity. Results: The medication was timely adjusted based on the therapy efficacy. At last, the patient successfully completed the cycle of chemotherapy. Conclusion: Clinical pharmacist should be familiar with mechanisms of drug action and adverse reactions, so that provide better pharmaceutical care service.
刘倩欣,向倩,李晓颖,赵楠,崔一民. 1例晚期肾癌术后并发感染患者治疗的用药监护[J]. 临床药物治疗杂志, 2016, 14(6): 81-84.
WANG Ming-mei, ZHOU Liang, ZHANG Xin, WANG Xin-hui, WEI Jin-fei, LIU Gui-yang. Case report of pharmaceutical care of a renal cell carcinoma patient with postoperative infection. CLINICAL MEDICATION JOURNAL, 2016, 14(6): 81-84.
2016, Vol. 14 
